These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation. Kassam G, Le BH, Choi KS, Kang HM, Fitzpatrick SL, Louie P, Waisman DM. Biochemistry; 1998 Dec 01; 37(48):16958-66. PubMed ID: 9836589 [Abstract] [Full Text] [Related]
10. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers. Weckroth M, Vaheri A, Virolainen S, Saarialho-Kere U, Jahkola T, Sirén V. Br J Dermatol; 2004 Dec 02; 151(6):1189-96. PubMed ID: 15606514 [Abstract] [Full Text] [Related]
11. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors. Kwon M, MacLeod TJ, Zhang Y, Waisman DM. Front Biosci; 2005 Jan 01; 10():300-25. PubMed ID: 15574370 [Abstract] [Full Text] [Related]
13. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells. Yasui H, Suzuki Y, Sano H, Suda T, Chida K, Dan T, Miyata T, Urano T. Thromb Res; 2013 Jul 01; 132(1):100-5. PubMed ID: 23611258 [Abstract] [Full Text] [Related]
14. Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression. Sharma MR, Koltowski L, Ownbey RT, Tuszynski GP, Sharma MC. Exp Mol Pathol; 2006 Oct 01; 81(2):146-56. PubMed ID: 16643892 [Abstract] [Full Text] [Related]
15. Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator--requirement for a co-receptor? Camani C, Gavin O, Kruithof EK. Thromb Haemost; 2000 Feb 01; 83(2):290-6. PubMed ID: 10739388 [Abstract] [Full Text] [Related]